Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study
The Journal of Dermatology · 2025
DOI: 10.1111/1346-8138.17702 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Seong Jin Jo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Psoriasis, Dermatologic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johnson & Johnson Innovative Medicine..
Abstract (Originalsprache)
Palmoplantar pustulosis (PPP) is a chronic skin disease characterized by erythema, pustules, and desquamation of the palms and soles. PPP epidemiological data are scarce. Understanding disease characteristic is essential for effective management and to reduce burden. The objective of the study was to describe disease characteristics of PPP in Korea, including demographics, disease burden, and current clinical practice. This was a cross‐sectional, multicenter, noninterventional study conducted among 20 sites in Korea. Patients (aged ≥19 years) with a confirmed PPP diagnosis were examined and interviewed, collecting clinical and patient‐reported outcomes in 1 day. A total of 379 patients with PPP (mean age, 51.4 years; 39.3% male) were enrolled. The mean age at diagnosis was 47.9 years, and the mean duration of PPP was 3.2 years. Mean±standard deviation of Palmoplantar Pustulosis Area and Severity Index (PPPASI) score was 10.3±9.0; 33.8% of patients scored ≥12. PPPASI score was significantly higher with younger age ( p = 0.0001) and nail involvement ( p = 0.0002). Mean Dermatology Life Quality Index (DLQI) score was 12.0, and mean EuroQoL 5‐Dimension Health Questionnaire (EQ‐5D) score was 62.4 ± 19. Patients with PPPASI ≥12 had significantly higher DLQI (14.1 ± 7.3 vs 10.9 ± 7.6; p < 0.0001) and lower EQ‐5D (57.9 ± 18.1 vs 64.7 ± 19.2; p = 0.002) scores. The most common treatments in patients with PPPASI
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.
- Department of Dermatology, Pusan National University School of Medicine, Busan, Korea.
- Department of Dermatology, CHA University Bundang Medical Center, Seongnam, Korea.
- Department of Dermatology, Gangnam Severance Hospital, Seoul, Korea.
- Department of Dermatology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea.
- Department of Dermatology, Korea University Ansan Hospital, Ansan, Korea.
ORCID-Profile: Seong Jin Jo, Byung Soo Kim, Dong Hyun Kim, Jong Hoon Kim, Jiyoung Ahn, Jihye An, Sang Woong Youn
Förderung
- Johnson & Johnson Innovative Medicine.
Zitieren
APA
Jo, S. J., Kim, B. S., Kim, D. H., Kim, J. H., Park, C. W., Son, S. W., Ahn, J., Lee, J. Y., Jeong, K. H., Kim, Y., An, J., Park, C. J., & Youn, S. W. (2025). Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17702
Vancouver
Jo SJ, Kim BS, Kim DH, Kim JH, Park CW, Son SW, et al. Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17702
BibTeX
@article{Jo2025,
author = {Jo, Seong Jin and Kim, Byung Soo and Kim, Dong Hyun and Kim, Jong Hoon and Park, Chun Wook and Son, Sang Wook and Ahn, Jiyoung and Lee, Ji Yeoun and Jeong, Ki-Heon and Kim, Youngdoe and An, Jihye and Park, Chul Jong and Youn, Sang Woong},
title = {Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study},
journal = {The Journal of Dermatology},
year = {2025},
doi = {10.1111/1346-8138.17702}
}
EUVIMED